Person: Dr Christopher Gallen

Dr Christopher Gallen

Dr Christopher Gallen has been appointed president and CEO of Vancouver-based Neuromed Technologies Inc, a private biopharmaceutical firm focused on drugs for chronic pain. He replaces founding president

Natalie Dakers

Natalie Dakers (see below), who helped the firm move through Phase I clinical trials and raise $70 million in venture capital financing. Gallen was most recently with Wyeth Research where he held the posi